{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:43:12Z","timestamp":1782513792227,"version":"3.54.5"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10549-019-05516-1","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T19:04:30Z","timestamp":1577991870000},"page":"1-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Uterine cancer in breast cancer survivors: a systematic review"],"prefix":"10.1007","volume":"180","author":[{"given":"Akemi T.","family":"Wijayabahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1626-5340","authenticated-orcid":false,"given":"Lusine","family":"Yaghjyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"5516_CR1","unstructured":"American Cancer Society ACS (2018) Cancer Facts & Figures, Atlanta"},{"key":"5516_CR2","unstructured":"Surveillance E, and End Results Program (2018) Female Breast Cancer\u2014Cancer Stat Facts. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"issue":"4","key":"5516_CR3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ijc.29462","volume":"137","author":"F Ricceri","year":"2015","unstructured":"Ricceri F, Fasanelli F, Giraudo MT, Sieri S, Tumino R, Mattiello A, Vagliano L, Masala G, Quiros JR, Travier N, Sanchez MJ, Larranaga N, Chirlaque MD, Ardanaz E, Tjonneland A, Olsen A, Overvad K, Chang-Claude J, Kaaks R, Boeing H, Clavel-Chapelon F, Kvaskoff M, Dossus L, Trichopoulou A, Benetou V, Adarakis G, Bueno-de-Mesquita HB, Peeters PH, Sund M, Andersson A, Borgquist S, Butt S, Weiderpass E, Skeie G, Khaw KT, Travis RC, Rinaldi S, Romieu I, Gunter M, Kadi M, Riboli E, Vineis P, Sacerdote C (2015) Risk of second primary malignancies in women with breast cancer: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 137(4):940\u2013948","journal-title":"Int J Cancer"},{"issue":"6","key":"5516_CR4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4174\/astr.2017.93.6.287","volume":"93","author":"HK Jung","year":"2017","unstructured":"Jung HK, Park S, Kim NW, Lee JE, Kim Z, Han SW, Hur SM, Kim SY, Lim CW, Lee MH, Lee J (2017) Development of second primary cancer in Korean breast cancer survivors. Ann Surg Treat Res 93(6):287\u2013292","journal-title":"Ann Surg Treat Res"},{"issue":"2","key":"5516_CR5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ygyno.2013.04.057","volume":"130","author":"E Molina-Montes","year":"2013","unstructured":"Molina-Montes E, Pollan M, Payer T, Molina E, Davila-Arias C, Sanchez MJ (2013) Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain). Gynecol Oncol 130(2):340\u2013345","journal-title":"Gynecol Oncol"},{"issue":"5","key":"5516_CR6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00432-018-2621-9","volume":"144","author":"G Corso","year":"2018","unstructured":"Corso G, Veronesi P, Santomauro GI, Maisonneuve P, Morigi C, Peruzzotti G, Intra M, Sacchini V, Galimberti V (2018) Multiple primary non-breast tumors in breast cancer survivors. J Cancer Res Clin Oncol 144(5):979\u2013986","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"5516_CR7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10549-011-1560-9","volume":"129","author":"HH Nsouli-Maktabi","year":"2011","unstructured":"Nsouli-Maktabi HH, Henson DE, Younes N, Young HA, Cleary SD (2011) Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age. Breast Cancer Res Treat 129(3):963\u2013969","journal-title":"Breast Cancer Res Treat"},{"key":"5516_CR8","unstructured":"Casey MJ, Crotzer D (2019) Cancer, Endometrial. In: StatPearls (ed) StatPearls Publishing LLC, Treasure Island (FL)"},{"issue":"3","key":"5516_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12672-018-0330-0","volume":"9","author":"Z Li","year":"2018","unstructured":"Li Z, Wu Q, Song J, Zhang Y, Zhu S, Sun S (2018) Risk of second primary female genital malignancies in women with breast cancer: a SEER analysis. Horm Cancer 9(3):197\u2013204","journal-title":"Horm Cancer"},{"issue":"10","key":"5516_CR10","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ejso.2014.05.007","volume":"40","author":"C Ngo","year":"2014","unstructured":"Ngo C, Brugier C, Plancher C, de la Rochefordiere A, Alran S, Feron JG, Malhaire C, Scholl S, Sastre X, Rouzier R, Fourchotte V (2014) Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients. Eur J Surg Oncol 40(10):1237\u20131244","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"5516_CR11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2014.10.029","volume":"136","author":"E Molina-Montes","year":"2015","unstructured":"Molina-Montes E, Requena M, Sanchez-Cantalejo E, Fernandez MF, Arroyo-Morales M, Espin J, Arrebola JP, Sanchez MJ (2015) Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol Oncol 136(1):158\u2013171","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5516_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10549-006-9446-y","volume":"105","author":"A Trentham-Dietz","year":"2007","unstructured":"Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM (2007) Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat 105(2):195\u2013207","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5516_CR13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10549-012-2187-1","volume":"135","author":"N Druesne-Pecollo","year":"2012","unstructured":"Druesne-Pecollo N, Touvier M, Barrandon E, Chan DS, Norat T, Zelek L, Hercberg S, Latino-Martel P (2012) Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat 135(3):647\u2013654","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5516_CR14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10689-015-9798-8","volume":"14","author":"Y Segev","year":"2015","unstructured":"Segev Y, Rosen B, Lubinski J, Gronwald J, Lynch HT, Moller P, Kim-Sing C, Ghadirian P, Karlan B, Eng C, Gilchrist D, Neuhausen SL, Eisen A, Friedman E, Euhus D, Ping S, Narod SA (2015) Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study. Fam Cancer 14(3):383\u2013391","journal-title":"Fam Cancer"},{"key":"5516_CR15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2017.07.004","volume":"84","author":"YC Lee","year":"2017","unstructured":"Lee YC, Milne RL, Lheureux S, Friedlander M, McLachlan SA, Martin KL, Bernardini MQ, Smith C, Picken S, Nesci S, Hopper JL, Phillips KA (2017) Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers. Eur J Cancer 84:114\u2013120","journal-title":"Eur J Cancer"},{"issue":"1","key":"5516_CR16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2008.08.035","volume":"112","author":"AE Bland","year":"2009","unstructured":"Bland AE, Calingaert B, Secord AA, Lee PS, Valea FA, Berchuck A, Soper JT, Havrilesky L (2009) Relationship between tamoxifen use and high risk endometrial cancer histologic types. Gynecol Oncol 112(1):150\u2013154","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5516_CR17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3892\/mco.2014.250","volume":"2","author":"C Dong","year":"2014","unstructured":"Dong C, Chen L (2014) Second malignancies after breast cancer: the impact of adjuvant therapy. Mol Clin Oncol 2(3):331\u2013336","journal-title":"Mol Clin Oncol"},{"issue":"5","key":"5516_CR18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6604241","volume":"98","author":"Kirova YM, De Rycke Y, Gambotti L, Pierga JY, Asselain B, Fourquet A, Institut Curie Breast Cancer Study G","year":"2008","unstructured":"Kirova YM, De Rycke Y, Gambotti L, Pierga JY, Asselain B, Fourquet A, Institut Curie Breast Cancer Study G (2008) Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer 98(5):870\u2013874","journal-title":"Br J Cancer"},{"issue":"6","key":"5516_CR19","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1245\/s10434-014-4193-5","volume":"22","author":"D Torres","year":"2015","unstructured":"Torres D, Myers JA, Eshraghi LW, Riley EC, Soliman PT, Milam MR (2015) Risk factors for the development of uterine cancer in breast cancer survivors: an army of women study. Ann Surg Oncol 22(6):1974\u20131979","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5516_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-015-3315-5","volume":"150","author":"J Liu","year":"2015","unstructured":"Liu J, Jiang W, Mao K, An Y, Su F, Kim BY, Liu Q, Jacobs LK (2015) Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis. Breast Cancer Res Treat 150(2):439\u2013445","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"5516_CR21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/sj.bjc.6603172","volume":"94","author":"JS Raymond","year":"2006","unstructured":"Raymond JS, Hogue CJR (2006) Multiple primary tumours in women following breast cancer, 1973\u20132000. Br J Cancer 94(11):1745\u20131750. https:\/\/doi.org\/10.1038\/sj.bjc.6603172","journal-title":"Br J Cancer"},{"key":"5516_CR22","volume-title":"DistillerSR forest plot generator","author":"Partners SRaLRSbE","year":"2019","unstructured":"Partners SRaLRSbE (2019) DistillerSR forest plot generator. Evidence Partners, Canada"},{"issue":"2","key":"5516_CR23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7150\/jca.8412","volume":"5","author":"JY Chen","year":"2014","unstructured":"Chen JY, Kuo SJ, Liaw YP, Avital I, Stojadinovic A, Man YG, Mannion C, Wang J, Chou MC, Tsai HD, Chen ST, Hsiao YH (2014) Endometrial cancer incidence in breast cancer patients correlating with age and duration of tamoxifen use: a population based study. J Cancer 5(2):151\u2013155","journal-title":"J Cancer"},{"issue":"6","key":"5516_CR24","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cam4.1473","volume":"7","author":"MC Chen","year":"2018","unstructured":"Chen MC, Lee KD, Lu CH, Wang TY, Huang SH, Chen CY (2018) The bidirectional association among female hormone-related cancers: breast, ovary, and uterine corpus. Cancer Med 7(6):2299\u20132306","journal-title":"Cancer Med"},{"issue":"8","key":"5516_CR25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/IGC.0b013e3181b9f5d5","volume":"19","author":"L Cortesi","year":"2009","unstructured":"Cortesi L, De Matteis E, Rashid I, Cirilli C, Proietto M, Rivasi F, Federico M (2009) Distribution of second primary malignancies suggests a bidirectional effect between breast and endometrial cancer: a population-based study. Int J Gynecol Cancer 19(8):1358\u20131363","journal-title":"Int J Gynecol Cancer"},{"key":"5516_CR26","first-page":"1239","volume":"8","author":"X Liu","year":"2015","unstructured":"Liu X, Zhao F, Hu L, Sun Y (2015) Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes. Onco Targets Ther 8:1239\u20131243","journal-title":"Onco Targets Ther"},{"issue":"10","key":"5516_CR27","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1158\/1055-9965.EPI-08-0109","volume":"17","author":"KD Lee","year":"2008","unstructured":"Lee KD, Chen SC, Chan CH, Lu CH, Chen CC, Lin JT, Chen MF, Huang SH, Yeh CM, Chen MC (2008) Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomark Prev 17(10):2647\u20132655","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"5516_CR28","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/ijc.21651","volume":"118","author":"L Mellemkjaer","year":"2006","unstructured":"Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Kee-Seng C, Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P, Brennan P (2006) Risk of second cancer among women with breast cancer. Int J Cancer 118(9):2285\u20132292","journal-title":"Int J Cancer"},{"issue":"5","key":"5516_CR29","first-page":"963","volume":"2","author":"Y Kamigaki","year":"2011","unstructured":"Kamigaki Y, Kawakami K (2011) Risk of second cancer after initial treatment of breast cancer: an osaka cancer registry database study. Oncol Lett 2(5):963\u2013973","journal-title":"Oncol Lett"},{"issue":"4","key":"5516_CR30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/02841860801978921","volume":"47","author":"M Andersson","year":"2008","unstructured":"Andersson M, Jensen MB, Engholm G, Henrik Storm H (2008) Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer Cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977\u20132001. Acta Oncol 47(4):755\u2013764","journal-title":"Acta Oncol"},{"issue":"8","key":"5516_CR31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2007.11.9081","volume":"26","author":"M Schaapveld","year":"2008","unstructured":"Schaapveld M, Visser O, Louwman MJ, de Vries EG, Willemse PH, Otter R, van der Graaf WT, Coebergh JW, van Leeuwen FE (2008) Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population\u2014based study. J Clin Oncol 26(8):1239\u20131246","journal-title":"J Clin Oncol"},{"issue":"5","key":"5516_CR32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jnci\/dji057","volume":"97","author":"AJ Swerdlow","year":"2005","unstructured":"Swerdlow AJ, Jones ME (2005) Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case\u2013control study. J Natl Cancer Inst 97(5):375\u2013384","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5516_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-005-4016-2","volume":"93","author":"I Soerjomataram","year":"2005","unstructured":"Soerjomataram I, Louwman WJ, de Vries E, Lemmens VEPP, Klokman WJ, Coebergh JWW (2005) Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972\u20132001. Breast Cancer Res Treat 93(1):91\u201395","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5516_CR34","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.7150\/jca.8412","volume":"5","author":"JY Chen","year":"2014","unstructured":"Chen JY, Kuo SJ, Liaw YP, Avital I, Stojadinovic A, Man YG, Mannion C, Wang J, Chou MC, Tsai HD, Chen ST (2014) Endometrial cancer incidence in breast cancer patients correlating with age and duration of tamoxifen use: a population based study. J Cancer 5(2):e151","journal-title":"J Cancer"},{"issue":"9233","key":"5516_CR35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","volume":"356","author":"L Bergman","year":"2000","unstructured":"Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer comprehensive cancer centres' ALERT Group Assessment of liver and endometrial cancer risk following tamoxifen. Lancet 356(9233):881\u2013887","journal-title":"Lancet"},{"issue":"3","key":"5516_CR36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X","volume":"76","author":"H Mignotte","year":"1998","unstructured":"Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F (1998) Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study federation nationale des centres de lutte contre le cancer (FNCLCC). Int J Cancer 76(3):325\u2013330","journal-title":"Int J Cancer"},{"issue":"1","key":"5516_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1349-7006.2001.tb01040.x","volume":"92","author":"H Tanaka","year":"2001","unstructured":"Tanaka H, Tsukuma H, Koyama H, Kinoshita Y, Kinoshita N, Oshima A (2001) Second primary cancers following breast cancer in the Japanese female population. Jpn J Cancer Res 92(1):1\u20138","journal-title":"Jpn J Cancer Res"},{"issue":"13","key":"5516_CR38","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/cncr.29332","volume":"121","author":"RT Chlebowski","year":"2015","unstructured":"Chlebowski RT, Schottinger JE, Shi J, Chung J, Haque R (2015) Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors. Cancer 121(13):2147\u20132155","journal-title":"Cancer"},{"issue":"4","key":"5516_CR39","first-page":"289","volume":"2","author":"K Hajian-Tilaki","year":"2011","unstructured":"Hajian-Tilaki K (2011) Sample size estimation in epidemiologic studies. Caspian J Intern Med 2(4):289\u2013298","journal-title":"Caspian J Intern Med"},{"issue":"12","key":"5516_CR40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373\u20131379","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"5516_CR41","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/ndt\/gfp732","volume":"25","author":"M Noordzij","year":"2010","unstructured":"Noordzij M, Tripepi G, Dekker FW, Zoccali C, Tanck MW, Jager KJ (2010) Sample size calculations: basic principles and common pitfalls. Nephrol Dial Transpl 25(5):1388\u20131393","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"5516_CR42","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1158\/1055-9965.EPI-11-0009","volume":"20","author":"L Mellemkjaer","year":"2011","unstructured":"Mellemkjaer L, Christensen J, Frederiksen K, Pukkala E, Weiderpass E, Bray F, Friis S, Andersson M, Olsen JH (2011) Risk of primary non-breast cancer after female breast cancer by age at diagnosis. Cancer Epidemiol Biomark Prev 20(8):1784\u20131792","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"5516_CR43","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-007-9509-8","volume":"106","author":"LM Brown","year":"2007","unstructured":"Brown LM, Chen BE, Pfeiffer RM, Schairer C, Hall P, Storm H, Pukkala E et al (2007) Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat 106(3):439\u2013451","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"5516_CR44","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3349\/ymj.2015.56.5.1213","volume":"56","author":"J Lee","year":"2015","unstructured":"Lee J, Park S, Kim S, Kim J, Ryu J, Park HS, Kim SI, Park BW (2015) Characteristics and survival of breast cancer patients with multiple synchronous or metachronous primary cancers. Yonsei Med J 56(5):1213\u20131220","journal-title":"Yonsei Med J"},{"key":"5516_CR45","unstructured":"Bray F, Ferlay J (2019) Chapter 5: data comparability and quality. World Health Organization, IARC. https:\/\/ci5.iarc.fr\/CI5-XI\/Pages\/Chapter5.aspx."},{"key":"5516_CR46","unstructured":"Association ICR (2017) Map of cancer registries. https:\/\/www.registri-tumori.it\/cms\/pagine\/mappa-dei-registri-di-popolazione."},{"issue":"3","key":"5516_CR47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2471\/BLT.15.164384","volume":"94","author":"S Antoni","year":"2016","unstructured":"Antoni S, Soerjomataram I, M\u00f8ller B, Bray F, Ferlay J (2016) An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence. Bull World Health Organ 94(3):174","journal-title":"Bull World Health Organ"},{"issue":"10","key":"5516_CR48","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pds.4267","volume":"27","author":"WH Kao","year":"2018","unstructured":"Kao WH, Hong JH, See LC, Yu HP, Hsu JT, Chou IJ, Chou WC, Chiou MJ, Wang CC, Kuo CF (2018) Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan. Pharmacoepidemiol Drug Saf 27(10):1060\u20131066","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"5516_CR49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/aje\/kwg006","volume":"157","author":"A Parikh-Patel","year":"2003","unstructured":"Parikh-Patel A, Allen M, Wright WE (2003) Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol 157(6):539\u2013545","journal-title":"Am J Epidemiol"},{"issue":"7","key":"5516_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/jech.2005.039131","volume":"60","author":"C Navarro","year":"2006","unstructured":"Navarro C, Chirlaque MD, Tormo MJ, P\u00e9rez-Flores D, Rodr\u00edguez-Barranco M, S\u00e1nchez-Villegas A, Agudo A, Pera G, Amiano P, Dorronsoro M, Larra\u00f1aga N, Quir\u00f3s JR, Ardanaz E, Barricarte A, Mart\u00ednez C, S\u00e1nchez MJ, Berenguer A, Gonz\u00e1lez CA (2006) Validity of self reported diagnoses of cancer in a major Spanish prospective cohort study. J Epidemiol Community Health 60(7):593\u2013599. https:\/\/doi.org\/10.1136\/jech.2005.039131","journal-title":"J Epidemiol Community Health"},{"key":"5516_CR51","unstructured":"Oncology ASoC (2012) Uterine cancer\u2014risk factors and prevention. https:\/\/www.cancer.net\/cancer-types\/uterine-cancer\/risk-factors-and-prevention."},{"key":"5516_CR52","unstructured":"Society AC (2019) Endometrial cancer risk factors."},{"issue":"4","key":"5516_CR53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4048\/jbc.2015.18.4.378","volume":"18","author":"R Marcheselli","year":"2015","unstructured":"Marcheselli R, Marcheselli L, Cortesi L, Bari A, Cirilli C, Pozzi S, Ferri P, Napolitano M, Federico M, Sacchi S (2015) Risk of second primary malignancy in breast cancer survivors: a nested population-based case\u2013control study. J Breast Cancer 18(4):378\u2013385","journal-title":"J Breast Cancer"},{"issue":"1","key":"5516_CR54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.maturitas.2010.04.015","volume":"67","author":"AI Phipps","year":"2010","unstructured":"Phipps AI, Ichikawa L, Bowles EJ, Carney PA, Kerlikowske K, Miglioretti DL, Buist DS (2010) Defining menopausal status in epidemiologic studies: a comparison of multiple approaches and their effects on breast cancer rates. Maturitas 67(1):60\u201366","journal-title":"Maturitas"},{"issue":"1","key":"5516_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-014-2905-y","volume":"145","author":"A Trentham-Dietz","year":"2014","unstructured":"Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA (2014) Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies. Breast Cancer Res Treat 145(1):165\u2013175","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5516_CR56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/hmbci-2013-0007","volume":"14","author":"JA Eden","year":"2013","unstructured":"Eden JA (2013) Menopausal status, adipose tissue, and breast cancer risk: impact of estrogen replacement therapy. Horm Mol Biol Clin Investig 14(2):57\u201363","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"8","key":"5516_CR57","first-page":"364","volume":"106","author":"M Bonotto","year":"2015","unstructured":"Bonotto M, Puglisi F (2015) Early breast cancer in pre-menopausal women and endocrine treatment: which factors impact on decision-making process? Recent Prog Med 106(8):364\u2013369","journal-title":"Recent Prog Med"},{"key":"5516_CR58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsbmb.2013.06.010","volume":"142","author":"J Sr","year":"2014","unstructured":"Sr J (2014) Menopausal hormone therapy and breast cancer. J Steroid Biochem Mol Biol 142:52\u201361","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"5516_CR59","first-page":"448","volume":"78","author":"AT Ali","year":"2013","unstructured":"Ali AT (2013) Risk factors for endometrial cancer. Ceska Gynekol 78(5):448\u2013459","journal-title":"Ceska Gynekol"},{"issue":"1","key":"5516_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5114\/pm.2016.58767","volume":"15","author":"K Plagens-Rotman","year":"2016","unstructured":"Plagens-Rotman K, \u017bak E, Pi\u0119ta B (2016) Odds ratio analysis in women with endometrial cancer. Prz Menopauzalny 15(1):12\u201319. https:\/\/doi.org\/10.5114\/pm.2016.58767","journal-title":"Prz Menopauzalny"},{"issue":"3","key":"5516_CR61","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwk010","volume":"165","author":"VW Setiawan","year":"2006","unstructured":"Setiawan VW, Pike MC, Kolonel LN, Nomura AM, Goodman MT, Henderson BE (2006) Racial\/ethnic differences in endometrial cancer risk: the Multiethnic Cohort Study. Am J Epidemiol 165(3):262\u2013270","journal-title":"Am J Epidemiol"},{"issue":"1","key":"5516_CR62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/107327480901600108","volume":"16","author":"JE Allard","year":"2009","unstructured":"Allard JE, Maxwell GL (2009) Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control 16(1):53\u201356","journal-title":"Cancer Control"},{"issue":"2","key":"5516_CR63","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10552-014-0510-3","volume":"26","author":"ML Cote","year":"2015","unstructured":"Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B, Lee E, Horn-Ross PL, Kolonel LN, Kaunitz A, Liang X, Nicholson WK, Park AB, Petruzella S, Rebbeck TR, Setiawan VW, Signorello LB, Simon MS, Weiss NS, Wentzensen N, Yang HP, Zeleniuch-Jacquotte A, Olson SH (2015) Risk factors for endometrial cancer in black and white women: a pooled analysis from the epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes Control 26(2):287\u2013296","journal-title":"Cancer Causes Control"},{"issue":"4","key":"5516_CR64","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10552-016-0724-7","volume":"27","author":"OA Babatunde","year":"2016","unstructured":"Babatunde OA, Adams SA, Eberth JM, Wirth MD, Choi SK, Hebert JR (2016) Racial disparities in endometrial cancer mortality-to-incidence ratios among blacks and whites in South Carolina. Cancer Causes Control 27(4):503\u2013511","journal-title":"Cancer Causes Control"},{"issue":"7","key":"5516_CR65","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ijc.31961","volume":"145","author":"O Raglan","year":"2018","unstructured":"Raglan O, Kalliala I, Markozannes G, Cividini S, Gunter MJ, Nautiyal J, Gabra H, Paraskevaidis E, Martin-Hirsch P, Tsilidis KK, Kyrgiou M (2018) Risk factors for endometrial cancer: an umbrella review of the literature. Int J Cancer 145(7):1719\u20131730","journal-title":"Int J Cancer"},{"issue":"8","key":"5516_CR66","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/annonc\/mdv142","volume":"26","author":"D Aune","year":"2015","unstructured":"Aune D, Navarro Rosenblatt DA, Chan DS, Vingeliene S, Abar L, Vieira AR, Greenwood DC, Bandera EV, Norat T (2015) Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Ann Oncol 26(8):1635\u20131648","journal-title":"Ann Oncol"},{"issue":"1","key":"5516_CR67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","volume":"16","author":"M Arnold","year":"2015","unstructured":"Arnold M, Pandeya N, Byrnes G, Renehan PAG, Stevens GA, Ezzati PM, Ferlay J, Miranda JJ, Romieu I, Dikshit R, Forman D, Soerjomataram I (2015) Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 16(1):36\u201346","journal-title":"Lancet Oncol"},{"issue":"2 Pt 1","key":"5516_CR68","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/AOG.0000000000000381","volume":"124","author":"NS Nevadunsky","year":"2014","unstructured":"Nevadunsky NS, Van Arsdale A, Strickler HD, Moadel A, Kaur G, Levitt J, Girda E, Goldfinger M, Goldberg GL, Einstein MH (2014) Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol 124(2 Pt 1):300\u2013306","journal-title":"Obstet Gynecol"},{"issue":"9","key":"5516_CR69","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2105\/ajph.2016.303337","volume":"106","author":"BM Birmann","year":"2016","unstructured":"Birmann BM, Barnard ME, Bertrand KA, Bao Y, Crous-Bou M, Wolpin BM, De Vivo I, Tworoger SS (2016) Nurses\u2019 health study contributions on the epidemiology of less common cancers: endometrial, ovarian, pancreatic, and hematologic. Am J Public Health 106(9):1608\u20131615. https:\/\/doi.org\/10.2105\/ajph.2016.303337","journal-title":"Am J Public Health"},{"issue":"7","key":"5516_CR70","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.puhe.2015.04.017","volume":"129","author":"E Jenabi","year":"2015","unstructured":"Jenabi E, Poorolajal J (2015) The effect of body mass index on endometrial cancer: a meta-analysis. Public Health 129(7):872\u2013880","journal-title":"Public Health"},{"issue":"6","key":"5516_CR71","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjmed.2008.01.044","volume":"121","author":"B Zhou","year":"2008","unstructured":"Zhou B, Yang L, Sun Q, Cong R, Gu H, Tang N, Zhu H, Wang B (2008) Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 121(6):501\u2013508.e503","journal-title":"Am J Med"},{"issue":"2","key":"5516_CR72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.annepidem.2012.11.009","volume":"23","author":"V Fedirko","year":"2013","unstructured":"Fedirko V, Jenab M, Rinaldi S, Biessy C, Allen NE, Dossus L, Onland-Moret NC, Schutze M, Tjonneland A, Hansen L, Overvad K, Clavel-Chapelon F, Chabbert-Buffet N, Kaaks R, Lukanova A, Bergmann MM, Boeing H, Trichopoulou A, Oustoglou E, Barbitsioti A, Saieva C, Tagliabue G, Galasso R, Tumino R, Sacerdote C, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Gram IT, Sanchez S, Duell EJ, Molina-Montes E, Arriola L, Chirlaque MD, Ardanaz E, Manjer J, Lundin E, Idahl A, Khaw KT, Romaguera-Bosch D, Wark PA, Norat T, Romieu I (2013) Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Ann Epidemiol 23(2):93\u201398","journal-title":"Ann Epidemiol"},{"issue":"2","key":"5516_CR73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00404-016-4263-y","volume":"295","author":"Q Zhou","year":"2017","unstructured":"Zhou Q, Guo P, Li H, Chen XD (2017) Does alcohol consumption modify the risk of endometrial cancer? A dose-response meta-analysis of prospective studies. Arch Gynecol Obstet 295(2):467\u2013479","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"5516_CR74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bjc.6605698","volume":"103","author":"E Friberg","year":"2010","unstructured":"Friberg E, Orsini N, Mantzoros CS, Wolk A (2010) Alcohol intake and endometrial cancer risk: a meta-analysis of prospective studies. Br J Cancer 103(1):127\u2013131","journal-title":"Br J Cancer"},{"issue":"1","key":"5516_CR75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/AOG.0000000000000563","volume":"125","author":"AK Win","year":"2015","unstructured":"Win AK, Reece JC, Ryan S (2015) Family history and risk of endometrial cancer: a systematic review and meta-analysis. Obstet Gynecol 125(1):89\u201398","journal-title":"Obstet Gynecol"},{"issue":"13","key":"5516_CR76","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1200\/JCO.2010.32.2933","volume":"29","author":"A Hackshaw","year":"2011","unstructured":"Hackshaw A, Roughton M, Forsyth S, Monson K, Reczko K, Sainsbury R, Baum M (2011) Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer. J Clin Oncol 29(13):1657\u20131663","journal-title":"J Clin Oncol"},{"key":"5516_CR77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/jco.2013.31.15_suppl.5","volume":"31","author":"Gray RG, Rea D, Handley K, Bowden SJ, Perry P, Earl HM, Poole CJ, Bates T, Chetiyawardana S, Dewar JA, Fernando IN, Grieve R, Nicoll J, Rayter Z, Robinson A, Salman A, Yarnold J, Bathers S, Marshall A, Lee M, Group obotaC","year":"2013","unstructured":"Gray RG, Rea D, Handley K, Bowden SJ, Perry P, Earl HM, Poole CJ, Bates T, Chetiyawardana S, Dewar JA, Fernando IN, Grieve R, Nicoll J, Rayter Z, Robinson A, Salman A, Yarnold J, Bathers S, Marshall A, Lee M, Group obotaC (2013) aTTom: long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer. J Clin Oncol 31:5\u20135","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05516-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T15:59:38Z","timestamp":1722268778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05516-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5516"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05516-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}